These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25054143)

  • 41. [Methods in molecular cytogenetics for determination of prognostically important chromosome changes in patients with chronic lymphatic leukemias].
    Jarosová M; Jedlicková K; Holzerová M; Urbanová R; Papajík T; Raida L; Pikalová Z; Lakomá I; Prekopová I; Kropácková J; Indrák K
    Cas Lek Cesk; 2000 Sep; 139(18):564-9. PubMed ID: 11109291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.
    Kröber A; Seiler T; Benner A; Bullinger L; Brückle E; Lichter P; Döhner H; Stilgenbauer S
    Blood; 2002 Aug; 100(4):1410-6. PubMed ID: 12149225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Genomic abnormalities detected by panel fluorescence in situ hybridization in chronic lymphocytic leukaemia].
    Li Q; Xue YQ; Jiang HY; Pan JL; Wu YF; Yang YB
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):324-6. PubMed ID: 15952127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia.
    Fabris S; Mosca L; Todoerti K; Cutrona G; Lionetti M; Intini D; Matis S; Colombo M; Agnelli L; Gentile M; Spriano M; Callea V; Festini G; Molica S; Lambertenghi Deliliers G; Morabito F; Ferrarini M; Neri A
    Genes Chromosomes Cancer; 2008 Sep; 47(9):781-93. PubMed ID: 18521849
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques.
    Martinet W; Knaapen MW; De Meyer GR; Herman AG; Kockx MM
    Circulation; 2002 Aug; 106(8):927-32. PubMed ID: 12186795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic lymphocytic leukaemia profiled for prognosis using a fluorescence in situ hybridisation panel.
    Reddy KS
    Br J Haematol; 2006 Mar; 132(6):705-22. PubMed ID: 16487171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterising the TP53-deleted subgroup of chronic lymphocytic leukemia: an analysis of additional cytogenetic abnormalities detected by interphase fluorescence in situ hybridisation and array-based comparative genomic hybridisation.
    Rudenko HC; Else M; Dearden C; Brito-Babapulle V; Jones C; Dexter T; Fenwick K; Mackay A; Ashworth A; Matutes E; Gonzalez D; Catovsky D; Morgan GJ
    Leuk Lymphoma; 2008 Oct; 49(10):1879-86. PubMed ID: 18949611
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of fluorescence in situ hybridization (FISH) in chronic lymphocytic leukemia (CLL).
    Gozzetti A; Crupi R; Tozzuoli D
    Hematology; 2004 Feb; 9(1):11-5. PubMed ID: 14965864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia.
    Dos Santos P; Panero J; Palau Nagore V; Stanganelli C; Bezares RF; Slavutsky I
    Tumour Biol; 2015 Nov; 36(11):8317-24. PubMed ID: 26008147
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Some genomic aberrations in B-cell chronic lymphocytic leukemia and their clinical relevance. Part I. B-cell lymphocytic leukemia with TP53 gene deletion].
    Koczkodaj D; Rupniewska ZM; Wasik-Szczepanek E; Bojarska-Junak A
    Pol Arch Med Wewn; 2003 Dec; 110(6):1395-403. PubMed ID: 15052934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories.
    Fiegl M; Erdel M; Tinhofer I; Brychtova Y; Panovska A; Doubek M; Eigenberger K; Fonatsch C; Hopfinger G; Mühlberger H; Zabernigg A; Falkner F; Gastl G; Mayer J; Greil R;
    Ann Oncol; 2010 Dec; 21(12):2410-2419. PubMed ID: 20466745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis.
    Greipp PT; Smoley SA; Viswanatha DS; Frederick LS; Rabe KG; Sharma RG; Slager SL; Van Dyke DL; Shanafelt TD; Tschumper RC; Zent CS
    Br J Haematol; 2013 Nov; 163(3):326-33. PubMed ID: 24032430
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chromosomal abnormalities by conventional cytogenetics and interphase fluorescence in situ hybridization in chronic lymphocytic leukemia in Taiwan, an area with low incidence--clinical implication and comparison between the West and the East.
    Wu SJ; Lin CT; Huang SY; Lee FY; Liu MC; Hou HA; Chen CY; Ko BS; Chou WC; Yao M; Tang JL; Tsay W; Tien HF
    Ann Hematol; 2013 Jun; 92(6):799-806. PubMed ID: 23417757
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Frequency of 5'IGH deletions in B-cell chronic lymphocytic leukemia.
    Quintero-Rivera F; Nooraie F; Rao PN
    Cancer Genet Cytogenet; 2009 Apr; 190(1):33-9. PubMed ID: 19264231
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The interphase fluorescence in situ hybridization (I-FISH) technique in patients with chronic lymphatic leukemia (CLL)].
    Michalová K; Zemanová Z; Cmunt E; Karban J; Brezinová J; Sindelárová L; Kurková S; Kubcová S; Schwarz J
    Cas Lek Cesk; 2000 Jun; 139(11):334-8. PubMed ID: 10953412
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimized mitogen stimulation induces proliferation of neoplastic B cells in chronic lymphocytic leukemia: significance for cytogenetic analysis.The Tampere Chronic Lympocytic Leukemia group.
    Larramendy ML; Siitonen SM; Zhu Y; Hurme M; Vilpo L; Vilpo JA; Knuutila S
    Cytogenet Cell Genet; 1998; 82(3-4):215-21. PubMed ID: 9858820
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia.
    Li H; Yi SH; Xiong WJ; Liu HM; Lyu R; Wang TY; Liu W; Zhong SZ; Yu Z; Zou DH; Xu Y; An G; Li ZJ; Qiu LG
    Chin Med J (Engl); 2017 Jan; 130(2):135-142. PubMed ID: 28091403
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clonal evolution in CLL patients as detected by FISH versus chromosome banding analysis, and its clinical significance.
    Wawrzyniak E; Kotkowska A; Blonski JZ; Siemieniuk-Rys M; Ziolkowska E; Giannopoulos K; Robak T; Korycka-Wolowiec A
    Eur J Haematol; 2014 Feb; 92(2):91-101. PubMed ID: 24138550
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytogenetic findings in familial B-cell chronic lymphocytic leukemia: a report of two cases in a family.
    Espinet B; Salido M; Hernández JA; Zamora L; Bosch MA; Serrano S; Solé F
    Cancer Genet Cytogenet; 2003 Jun; 143(2):172-3. PubMed ID: 12781453
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Possible benefits of tomato juice consumption: a pilot study on irradiated human lymphocytes from healthy donors.
    Nakamura A; Itaki C; Saito A; Yonezawa T; Aizawa K; Hirai A; Suganuma H; Miura T; Mariya Y; Haghdoost S
    Nutr J; 2017 May; 16(1):27. PubMed ID: 28494764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.